期刊文献+

血清抗中性粒细胞胞浆抗体及相关炎性因子检测对糖尿病肾病的诊断价值 被引量:8

Diagnostic Value of Detection Anti-Cardiolipin Antibodies and Related Inflammatory Factors in Diabetic Nephropathy
下载PDF
导出
摘要 目的探讨血清抗中性粒细胞胞浆抗体(ACA)、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)及超敏C-反应蛋白(hs-CRP)的检测对糖尿病肾病(DN)的诊断价值。方法选择2型糖尿病患者176例,依据尿微量清蛋白排泄率(UACR)分为单纯糖尿病组(DM组)、早期糖尿病肾病组(EDN组)和临床糖尿病肾病组(CN组),同时选取健康体检者60例作为对照组(NC组)。采用间接酶联免疫法检测ACA,免疫比浊法分析血清NGAL和hs-CRP水平。结果与NC组比较,DM组NGAL,hs-CRP及ACA-IgM水平升高,差异有统计学意义(P<0.05或P<0.01);EDN组NGAL,hs-CRP,ACA-IgG和ACA-IgA水平升高,差异均有统计学意义(P<0.05或P<0.01);CN组NGAL,hs-CRP,ACA-IgG和ACAIgA水平升高,差异有统计学意义(P<0.05或P<0.01);与DM组比较,EDN组NGAL和hs-CRP水平升高,差异有统计学意义(P<0.05),CN组NGAL,hs-CRP和ACA-IgA水平升高,差异有统计学意义(P<0.05或P<0.01);与EDN组比较,CN组NGAL和hs-CRP水平升高,差异有统计学意义(P<0.01)。NGAL,hs-CRP及ACA-IgA分别与ACR呈正相关(r=0.510,0.366,0.206,均P<0.01)。结论血清NGAL,hs-CRP和ACA-IgM可提示早期肾损害,NGAL,hs-CRP及ACA可作为DN病情进展过程中的监测指标。 Objective To investigate the diagnostic value of serum neutrophil gelatinase-associated lipocalin(NGAL), hypersensitive C-reactive protien(hs-CRP) and anti-cardiolipin antibodies(ACA) in diabetic nephropathy (DN). Methods 176 pa- tients with type 2 diabetes mellitus (T2DM)were divided into three groups according to anurinary albumin to creatinine ratio (ACR) ..diabetic mellitus group (DM group) , early diabetic nephropathy group (EDN group) and clinic diabetic nephropathy group (CN group). 60 healthy subjects in the same period determined by physical examination were enrolled as the control group (NC group). Analyzed ACA levels among 4 groups by indirect immunoIluorescence, while NGAL and hs-CRP were measured by immunoturbidimetry. Results Compared with NC group, NGAL, hs-CRP and anti-cardiolipin antibodies im- mune globulin M (ACA-IgM)levels in DM group were increased, and levels of NGAL, hs-CRP, anti-cardiolipin antibodies immune globulin G (ACA-IgG)and anti-cardiolipin antibodies immune globulin A (ACA-IgA) in EDN group and CN group were higher than those in NC group, the differences had statistical significance (p〈0.05 or p〈0.01). Compared with DM group, levels of NGAL and hs-CRP in EDN group were increased, while levels of NGAL, hs-CRP and ACA-IgA in CN group were also increased, the differences had statistical significance (p〈0.05 or p〈0.01), and CN group compared with EDN group, NGAL and hs-CRP levels were increased,the differences had statistical significance (p〈0.01). ACR was negatively correlated with NGAL, hs-CRP and ACA-IgA ( r= 0. 510,0. 366,0. 206, p〈0.01). Conclusion Levels of NGAL, hs-CRP and ACA-IgM can remind early renal damage, while levels of NGAL, hs-CRP and ACA can monitor the progress of DN.
作者 杨宏秀 刘丽 张会芬 袁宝军 夏彦东 YANG Hong xiu;LIU Li;ZHANG Hui fen;YUAN Bao jun;XIA Yan dong(Department of Clinical Laboratory,Kailuan General Hospital,Hebei Tangshan 063000,China)
出处 《现代检验医学杂志》 CAS 2018年第5期95-97,101,共4页 Journal of Modern Laboratory Medicine
关键词 抗中性粒细胞胞浆抗体 中性粒细胞明胶酶相关脂质运载蛋白 超敏C反应蛋白 糖尿病肾病 anti-cardiolipin antibodies neutrophil gelatinase-associated lipocalin hypersensitive C-reactive protein diabetic nephropathy
  • 相关文献

参考文献7

二级参考文献57

  • 1钱雅新,彭文,王浩.糖尿病肾病血清TGF-β_1改变及普伐他汀的治疗作用[J].实用诊断与治疗杂志,2006,20(2):117-119. 被引量:17
  • 2Morishita R, Aoki M, Hashiya N, et al. Therapeutic angiogenesis using hepatocyte growth factor (HGF) [J]. J Curr Gene Ther, 2004,4(2) :199 - 206.
  • 3Yoshida S, Harada T, Mitsunari M, et al. Hepatocyte growth factor/met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathways[J], Clin Endocrinol Metab,2004,89(2) =823 - 832.
  • 4Nishimura M, Ushiyama M, Ohtsuka K, et al. Serum hepatocyte growth factor as a possible indicator of vascular lesions[J]. J Clin Endocrinol Metab, 1999,84 (7): 2475 - 2480.
  • 5Tsehoepe D, Roesen P, Schwippert B, et al. Platelets in diabetes: The role in the hemostatic regulation in atheroselerosis[J]. Semin Thromb Hemost,1993,19(2) :122 - 128.
  • 6Nakagami H, Morishita R, Yamamoto K,et al. Hepatoeyte growth factor prevents endothelial cell death through inhibition of bax transloeation from cytosol to mitochondrial membrane[J]. Diabe tes,2002,51(8) :2604 - 2611.
  • 7Morishita R, Nakamura S, Nakamura Y, et al. Potential role of an endothelium - specific growth factor, hepatocyte growth factor, on endot belial damage in diabetes mellit us[J]. Diabetes, 1997,46 (1) 138 - 142.
  • 8Morishita R, Aoki M, Hashiya N,et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease [J]. Circulation, 2004,44 (2) : 203 - 209.
  • 9American Diabetes Association. Diabetic Nephropathy. Diabe-tes Care, 2002,25(suppl 1) :S85-S89.
  • 10BolignanoD, Donato V? Coppolino G, et al. Neutrophil gelati-nase-associated lipocalin (NGAL) as a marker of kidney dam-age. Am J Kidney Dis, 2008, 52: 595-605.

共引文献86

同被引文献93

引证文献8

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部